Abstract
7014Background: Frontline AML induction produces 60-70% complete remission (CR) rates but relapse is a major source of failure. Beside stem cell transplant (SCT), few options exist for post-CR main...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.